Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long noncoding RNA FAM66C promotes tumor progression and glycolysis in intrahepatic cholangiocarcinoma by regulating hsa‐miR ‐23b‐3p/ KCND2 axis

21 Aug 2021

Abstract excerpt

Long noncoding RNAs (lncRNAs) are known to be the important regulators in cancer progression. However, the role of lncRNA FAM66C (FAM66C) is yet to be investigated in intrahepatic cholangiocarcinoma (ICC). This study aimed to investigate the effects and related mechanisms of FAM66C in ICC. Human ICC tissues and cell lines were collected. The expression levels of FAM66C, hsa-miR-23b-3p (miR-23b-3p), and KCND2 were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34418280
DOI: 10.1002/tox.23346

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long noncoding RNA FAM66C promotes tumor progression and glycolysis in intrahepatic cholangiocarcinoma by regulating hsa‐miR ‐23b‐3p/ KCND2 axisPMID 34418280Read ↗

UBA3 is a potential diagnostic marker and regulates the proliferation and migration in intrahepatic cholangiocarcinamaSemantic proximity Read ↗

A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinomaSemantic proximity Read ↗

Mutant KRAS and CK2 Cooperatively Stimulate SLC16A3 Activity to Drive Intrahepatic Cholangiocarcinoma ProgressionSemantic proximity Read ↗

Multi-omics-driven discovery of invasive patterns and treatment strategies in CA19-9 positive intrahepatic cholangiocarcinoma.Semantic proximity Read ↗

Identification and validation of a lactate metabolism-related six-gene prognostic signature in intrahepatic cholangiocarcinomaSemantic proximity Read ↗

Long noncoding RNA LINC00930 promotes PFKFB3-mediated tumor glycolysis and cell proliferation in nasopharyngeal carcinomaSemantic proximity Read ↗

Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinomaSemantic proximity Read ↗

Role of Glucose Metabolism Reprogramming in the Pathogenesis of CholangiocarcinomaSemantic proximity Read ↗

Genetic features associated with 18F-FDG uptake in intrahepatic cholangiocarcinomaSemantic proximity Read ↗

MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathwaySemantic proximity Read ↗

KDM5C Represses FASN-Mediated Lipid Metabolism to Exert Tumor Suppressor Activity in Intrahepatic CholangiocarcinomaSemantic proximity Read ↗

Identify bile acids metabolism-related biomarkers and prognostic factor in intrahepatic cholangiocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.